The company plans to launch its AI agent, codenamed Q9, later this year after beta testing in February and March, with the Q9 serving as the foundation model for its humanoid robo ...
2, 2024 — Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical ...
The company exhibits higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $38.23 Billion, which is 63.72x above the industry average, implying stronger profitability and ...